Search

Stephen Johnson

Examiner (ID: 9192, Phone: (571)272-6877 , Office: P/3641 )

Most Active Art Unit
3641
Art Unit(s)
2201, 3641
Total Applications
3122
Issued Applications
2552
Pending Applications
138
Abandoned Applications
437

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 1313579 [patent_doc_number] => 06610732 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-26 [patent_title] => 'Anti-constipation composition' [patent_app_type] => B2 [patent_app_number] => 10/138650 [patent_app_country] => US [patent_app_date] => 2002-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6071 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 231 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610732.pdf [firstpage_image] =>[orig_patent_app_number] => 10138650 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/138650
Anti-constipation composition May 5, 2002 Issued
Array ( [id] => 1202900 [patent_doc_number] => 06720345 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-13 [patent_title] => 'Semicarbazone derivatives and their use as thrombopoietin mimetics' [patent_app_type] => B1 [patent_app_number] => 10/129211 [patent_app_country] => US [patent_app_date] => 2002-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5324 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/720/06720345.pdf [firstpage_image] =>[orig_patent_app_number] => 10129211 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/129211
Semicarbazone derivatives and their use as thrombopoietin mimetics May 2, 2002 Issued
Array ( [id] => 6725619 [patent_doc_number] => 20030207931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'USE OF 3-(2-ETHYLPHENYL)-5-(3-METHOXYPHENYL)-1H-1,2,4-TRIAZOLE FOR THE TREATMENT OF AUTOIMMUNE DISEASES' [patent_app_type] => new [patent_app_number] => 10/137699 [patent_app_country] => US [patent_app_date] => 2002-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4125 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207931.pdf [firstpage_image] =>[orig_patent_app_number] => 10137699 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/137699
Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases May 2, 2002 Issued
Array ( [id] => 6329402 [patent_doc_number] => 20020198182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Malignant tumor metastasis inhibitors' [patent_app_type] => new [patent_app_number] => 10/135846 [patent_app_country] => US [patent_app_date] => 2002-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2995 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198182.pdf [firstpage_image] =>[orig_patent_app_number] => 10135846 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/135846
Malignant tumor metastasis inhibitors Apr 30, 2002 Issued
Array ( [id] => 7622232 [patent_doc_number] => 06977269 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-12-20 [patent_title] => 'Method of improving animal tissue quality' [patent_app_type] => utility [patent_app_number] => 10/136472 [patent_app_country] => US [patent_app_date] => 2002-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7277 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/977/06977269.pdf [firstpage_image] =>[orig_patent_app_number] => 10136472 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/136472
Method of improving animal tissue quality Apr 30, 2002 Issued
10/129235 Pharmaceutical compositions Apr 30, 2002 Abandoned
Array ( [id] => 6736104 [patent_doc_number] => 20030013739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Methods of using a combination of cyclooxygenase-2 selective inhibitors and thalidomide for the treatment of neoplasia' [patent_app_type] => new [patent_app_number] => 10/135793 [patent_app_country] => US [patent_app_date] => 2002-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17570 [patent_no_of_claims] => 309 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013739.pdf [firstpage_image] =>[orig_patent_app_number] => 10135793 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/135793
Methods of using a combination of cyclooxygenase-2 selective inhibitors and thalidomide for the treatment of neoplasia Apr 29, 2002 Abandoned
10/111957 Method for administering a phosphodiesterase 4 inhibitor Apr 28, 2002 Abandoned
Array ( [id] => 5788444 [patent_doc_number] => 20020160965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Cosmetic and dermatological formulations comprising flavonoids' [patent_app_type] => new [patent_app_number] => 10/128766 [patent_app_country] => US [patent_app_date] => 2002-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8775 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160965.pdf [firstpage_image] =>[orig_patent_app_number] => 10128766 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/128766
Cosmetic and dermatological preparation with flavonoids Apr 22, 2002 Issued
Array ( [id] => 1342626 [patent_doc_number] => 06586417 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'Ester and ether derivatives of 4-hydroxy 4-androstene-3,17-dione and a method for the regulation of athletic function in humans' [patent_app_type] => B1 [patent_app_number] => 10/063415 [patent_app_country] => US [patent_app_date] => 2002-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2594 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586417.pdf [firstpage_image] =>[orig_patent_app_number] => 10063415 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/063415
Ester and ether derivatives of 4-hydroxy 4-androstene-3,17-dione and a method for the regulation of athletic function in humans Apr 21, 2002 Issued
Array ( [id] => 5788837 [patent_doc_number] => 20020161038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Prodrugs of carbamate inhibitors of IMPDH' [patent_app_type] => new [patent_app_number] => 10/125617 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13092 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1360 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20020161038.pdf [firstpage_image] =>[orig_patent_app_number] => 10125617 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/125617
Prodrugs of carbamate inhibitors of IMPDH Apr 16, 2002 Issued
Array ( [id] => 6756422 [patent_doc_number] => 20030004199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Method for preventing or treating pulmonary inflammation by administering an endothelin antagonist' [patent_app_type] => new [patent_app_number] => 10/121039 [patent_app_country] => US [patent_app_date] => 2002-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2308 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20030004199.pdf [firstpage_image] =>[orig_patent_app_number] => 10121039 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/121039
Method for preventing or treating pulmonary inflammation by administering an endothelin antagonist Apr 10, 2002 Abandoned
09/936128 Use of metformin in the preparation of pharmaceutical compositions capable of inhibiting the enzyme dipeptidyl peptidase iv Apr 8, 2002 Abandoned
Array ( [id] => 6412774 [patent_doc_number] => 20020183240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Antineoplastic combinations' [patent_app_type] => new [patent_app_number] => 10/117161 [patent_app_country] => US [patent_app_date] => 2002-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4711 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183240.pdf [firstpage_image] =>[orig_patent_app_number] => 10117161 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/117161
Antineoplastic combinations Apr 4, 2002 Abandoned
Array ( [id] => 1337650 [patent_doc_number] => 06593331 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-15 [patent_title] => 'Method for treatment of pain' [patent_app_type] => B2 [patent_app_number] => 10/115785 [patent_app_country] => US [patent_app_date] => 2002-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6477 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593331.pdf [firstpage_image] =>[orig_patent_app_number] => 10115785 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/115785
Method for treatment of pain Apr 3, 2002 Issued
Array ( [id] => 1202880 [patent_doc_number] => 06720337 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-13 [patent_title] => 'Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxlmic acid derivative' [patent_app_type] => B2 [patent_app_number] => 10/106227 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5870 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 465 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/720/06720337.pdf [firstpage_image] =>[orig_patent_app_number] => 10106227 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/106227
Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxlmic acid derivative Mar 26, 2002 Issued
Array ( [id] => 1282039 [patent_doc_number] => 06642258 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Use of central cannabinoid receptor antagonist for preparing medicines' [patent_app_type] => B1 [patent_app_number] => 10/088704 [patent_app_country] => US [patent_app_date] => 2002-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1300 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642258.pdf [firstpage_image] =>[orig_patent_app_number] => 10088704 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/088704
Use of central cannabinoid receptor antagonist for preparing medicines Mar 20, 2002 Issued
Array ( [id] => 5845424 [patent_doc_number] => 20020132830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Use of beta 2 bronchodilator drugs' [patent_app_type] => new [patent_app_number] => 10/095846 [patent_app_country] => US [patent_app_date] => 2002-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6801 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132830.pdf [firstpage_image] =>[orig_patent_app_number] => 10095846 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/095846
Use of beta 2 bronchodilator drugs Mar 11, 2002 Abandoned
Array ( [id] => 6756364 [patent_doc_number] => 20030004141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Medical devices, compositions and methods for treating vulnerable plaque' [patent_app_type] => new [patent_app_number] => 10/096131 [patent_app_country] => US [patent_app_date] => 2002-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8101 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20030004141.pdf [firstpage_image] =>[orig_patent_app_number] => 10096131 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/096131
Medical devices, compositions and methods for treating vulnerable plaque Mar 7, 2002 Abandoned
Array ( [id] => 5845316 [patent_doc_number] => 20020132793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Use of methylphenidate compounds to enhance memory' [patent_app_type] => new [patent_app_number] => 10/087232 [patent_app_country] => US [patent_app_date] => 2002-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 24644 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132793.pdf [firstpage_image] =>[orig_patent_app_number] => 10087232 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/087232
Use of methylphenidate compounds to enhance memory Feb 27, 2002 Abandoned
Menu